Pulmonary Drug Delivery Systems Market Analysis

Application (Asthma, Cystic Fibrosis, COPD, Allergic Rhinitis)

The global pulmonary drug delivery systems market is segmented and analyzed for demand and supply by application into asthma, cystic fibrosis, COPD, allergic rhinitis, and others. Out of these segments, the COPD segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the higher prevalence and severity of this disease, backed by the fact that the treatment for COPD is subsidized by government policies and non-governmental organizations that are increasingly providing COPD treatment worldwide. Chronic obstructive pulmonary disease (COPD) can be life-threatening that requires immediate medical attention. For instance, COPD prevalence worldwide was 10% in 2019, accounting for 390 million cases among people over 40 years. Therefore, these factors are anticipated to drive segment growth during the forecast period.

Product (Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Accessories)

The global pulmonary drug delivery systems market is also segmented and analyzed for demand and supply by product into metered dose inhalers, dry powder inhalers, nebulizers, and accessories. Amongst these segments, the nebulizers segment is expected to garner a significant share. Nebulizers are highly used for the treatment of asthma and other respiratory diseases. Nebulizers come in two types, ultrasonic and jet nebulizers. Jet nebulizers can compress air and oxygen passing by narrow orifice. Additionally, nebulizers are the traditional method to cure respiratory diseases, hence, people are more inclined to use nebulizers over other methods. Furthermore, high export and import volumes of nebulizers across the globe are also expected to propel the growth of the segment over the forecast period.

Our in-depth analysis of the global market includes the following segments: